.png?width=300&height=120&name=Huma-AI-Logo-(Horizontal).png "Huma-AI-Logo"){kind=logo}
IVDR 2022: The Year In Review Webinar with IVD Insider Carlos Galamba Is the In Vitro Diagnostic Regulation (IVDR) wearing you down? If so, you’re...
Continue Reading
Huma.AI Is Among PharmStars Fall 2022 Graduates Today PharmStars, the pharma-focused accelerator for digital health startups, announced the...
Continue Reading
Can Machines Understand Cause and Effect? In the simplest terms, machine learning (ML) is based on the ability of algorithms to learn from data. To...
Continue Reading
Over the past decade, artificial intelligence (AI) and machine learning (ML) has become the breakthrough technology most likely to transform how...
Continue Reading
Making the Most of the Data Available is the Key to Driving Recruitment Clinical operations professionals must extract the information they need to...
Continue Reading
Leveraging Clinical Intelligence to Meet New Requirements for Diversity Properly representing patient populations in clinical trials means taking on...
Continue Reading
Why "Resistance to Change" Is the Biggest Blocker to Clinical Development Innovation When we talk about optimizing clinical development, we're...
Continue Reading
New eBook Reveals How Data-Driven Clinical Intelligence Empowers Sponsors Using Everyday Language Oct. 14, 2022, Palo Alto, CA - Huma.AI, a...
Continue Reading
We recently published an exclusive MedTech Intelligence interview with Carlos Galamba, Vice President, Intelligence and Innovation with RQM+. Galamba...
Continue Reading
New board members to provide expertise and guidance to help set strategic direction for Huma.AI into the future – appointments come during key phase...
Continue Reading.png){kind=logo}
.png?width=200&name=Huma-AI-Logo-(Horizontal-Reverse).png "Huma-AI-Logo-(Horizontal-Reverse)"){kind=logo}